AL

Alma Yesodot Ltd.

KVSR | TA

Overview

Corporate Details

ISIN(s):
IL0011731457
LEI:
Country:
Israel
Address:
HaBarzel 3, 6971005 Tel Aviv - Jaffa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kvasir focuses on developing innovative medical devices and diagnostic technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-24 17:08
Regulatory News Service
Opening of Trading on April 27 2025-ALMA YESODOT B1
Hebrew (modern) 118.8 KB
2025-04-23 11:59
Regulatory News Service
Identifying Details of New Security-ALMA YESODOT B1
Hebrew (modern) 87.5 KB
2024-11-05 15:46
Regulatory News Service
Changes in the company's name and security, effective as of November 7, 2024
Hebrew (modern) 108.5 KB
2024-10-29 18:37
Regulatory News Service
The sector classification of the company will be changed, as of October 31, 202…
Hebrew (modern) 121.3 KB
2024-10-29 17:20
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2023-05-22 23:20
Report Publication Announcement
Frost and Sullivan is terminating coverage , following the completion of its co…
Hebrew (modern) 174.5 KB
2023-05-22 23:20
Pre-Annual General Meeting Information
Frost and Sullivan is terminating coverage , following the completion of its co…
Russian 46.0 KB
2023-03-23 21:00
Investor Presentation
Analysis update following financial report- price target is updated to NIS 22.7
English 1.2 MB
2023-03-23 21:00
Legal Proceedings Report
Analysis update following financial report- price target is updated to NIS 22.7
Russian 71.0 KB
2022-12-11 20:40
Investor Presentation
Analysis update following financial report- price target is updated to NIS 32.9…
English 1.2 MB
2022-12-11 20:40
Business and Financial Review
Analysis update following financial report- price target is updated to NIS 32.9…
Russian 67.3 KB
2022-08-30 20:47
Investor Presentation
Analysis update report ,target price is at 47.6NIS
English 1.2 MB
2022-08-30 20:47
Business and Financial Review
Analysis update report ,target price is at 47.6NIS
Russian 63.9 KB
2022-08-18 16:58
Investor Presentation
Presentation
English 3.0 MB
2022-08-18 16:58
Pre-Annual General Meeting Information
Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Alma Yesodot Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alma Yesodot Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.